BioStem Technologies Inc. (BSEM) Financials
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | $302 | $17 | $7 | $4 | $3 |
| Cost of Revenue | $14 | $1 | $1 | $1 | $1 |
| Gross Profit | $288 | $15 | $6 | $3 | $1 |
| Total Operating Expenses | $257 | $23 | $11 | $4 | $3 |
| Operating Income | $31 | -$8 | -$5 | -$2 | -$2 |
| Non-Operating | |||||
| Net Interest Expense | -$1 | -$1 | -$0 | -$1 | -$1 |
| Income Tax Expense | -$1 | $0 | $0 | $0 | $0 |
| Net Income | |||||
| Net Income | $32 | -$8 | -$7 | -$1 | -$2 |
| Per Share Data | |||||
| Revenue Per Share | $18.44 | $1.21 | $0.60 | $0.37 | $0.27 |
| EPS (Basic) | $1.95 | -$0.62 | -$0.63 | -$0.12 | -$0.26 |
| EPS (Diluted) | $1.47 | -$0.62 | -$0.63 | -$0.12 | -$0.26 |
| Shares Outstanding | 16.4M | 13.7M | 11.4M | 11.7M | 9.2M |
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.